All Phenotypes Gck<tm1.1Mgn> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Gck^tm1.1Mgn
targeted mutation 1.1, Mark A Magnuson
MGI:2177709

Summary

5 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
hm1	Gck^tm1.1Mgn/Gck^tm1.1Mgn	129S6/SvEvTac-Gck^tm1.1Mgn	MGI:3590683
hm2	Gck^tm1.1Mgn/Gck^tm1.1Mgn	involves: 129S6/SvEvTac * C57BL/6	MGI:3590680
cn3	Gck^tm1.1Mgn/Gck^tm1.1Mgn Tg(Ins2-cre)25Mgn/0	involves: 129S6/SvEvTac * C57BL/6 * DBA/2	MGI:3603003
cn4	Gck^tm1.1Mgn/Gck⁺ Tg(Ins2-cre)25Mgn/0	involves: 129S6/SvEvTac * C57BL/6 * DBA/2	MGI:3603012
cn5	Gck^tm1.1Mgn/Gck^tm1.1Mgn Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺	involves: 129S6/SvEvTac * C57BL/6 * DBA/2	MGI:3603013

Allelic Composition	Gck^tm1.1Mgn/Gck^tm1.1Mgn
Genetic Background	129S6/SvEvTac-Gck^tm1.1Mgn

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gck^tm1.1Mgn mutation (1 available); any Gck mutation (59 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

homeostasis/metabolism

increased circulating glucose level ( J:51826 )

• slight increase in blood glucose concentration (165 mg/dl vs. 132 mg/dl in wild-type)

Allelic Composition	Gck^tm1.1Mgn/Gck^tm1.1Mgn
Genetic Background	involves: 129S6/SvEvTac * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gck^tm1.1Mgn mutation (1 available); any Gck mutation (59 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

homeostasis/metabolism

increased circulating glucose level ( J:51826 )

• about 10% increase in blood glucose concentration (194 mg/dl vs. 175 mg/dl in wild-type)

Allelic Composition	Gck^tm1.1Mgn/Gck^tm1.1Mgn Tg(Ins2-cre)25Mgn/0
Genetic Background	involves: 129S6/SvEvTac * C57BL/6 * DBA/2

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gck^tm1.1Mgn mutation (1 available); any Gck mutation (59 available)
Tg(Ins2-cre)25Mgn mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

neonatal lethality, incomplete penetrance ( J:51826 )

• more than 80% neonatal mortality as a result of severe hyperglycemia

homeostasis/metabolism

hyperglycemia ( J:51826 )

• highly variable but increased blood glucose concentrations

decreased circulating insulin level ( J:51826 )

• decreased by about 70%

decreased liver glycogen level ( J:51826 )

• diminished hepatic glycogen

liver/biliary system

decreased liver glycogen level ( J:51826 )

• diminished hepatic glycogen

hepatic steatosis ( J:51826 )

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
maturity-onset diabetes of the young type 2		DOID:0111100	OMIM:125851	J:51826

Allelic Composition	Gck^tm1.1Mgn/Gck⁺ Tg(Ins2-cre)25Mgn/0
Genetic Background	involves: 129S6/SvEvTac * C57BL/6 * DBA/2

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gck^tm1.1Mgn mutation (1 available); any Gck mutation (59 available)
Tg(Ins2-cre)25Mgn mutation (2 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

homeostasis/metabolism

decreased insulin secretion ( J:51826 )

• 70% decrease in insulin secretion during hyperglycemic clamp studies

hyperglycemia ( J:51826 )

• blood glucose concentration is increased by about 50% compared to heterozygous Gck^tm1.1Mgn mice

• under fasting conditions, have a 25% increase in blood glucose concentration, without differences in basal insulin concentration

impaired glucose tolerance ( J:51826 )

• glucose turnover and glucose infusion rates during hyperglycemic clamp are reduced by about 60 and 70%, respectively

decreased glycogen level ( J:51826 )

• net glycogen synthesis in liver is reduced by about 50% during hyperglycemic clamp studies

endocrine/exocrine glands

decreased insulin secretion ( J:51826 )

• 70% decrease in insulin secretion during hyperglycemic clamp studies

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
maturity-onset diabetes of the young type 2		DOID:0111100	OMIM:125851	J:51826

Allelic Composition	Gck^tm1.1Mgn/Gck^tm1.1Mgn Speer6-ps1^{Tg(Alb-cre)21Mgn}/Speer6-ps1⁺
Genetic Background	involves: 129S6/SvEvTac * C57BL/6 * DBA/2

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gck^tm1.1Mgn mutation (1 available); any Gck mutation (59 available)
Speer6-ps1^{Tg(Alb-cre)21Mgn} mutation (6 available); any Speer6-ps1 mutation (4 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

homeostasis/metabolism

abnormal glucose homeostasis ( J:51826 )

decreased insulin secretion ( J:51826 )

• secrete 70% less insulin in response to glucose stimulus

increased circulating glucose level ( J:51826 )

• 10% increase in fed blood glucose concentration

increased circulating insulin level ( J:51826 )

• post-absorptive (fed) plasma insulin concentrations twice that of controls

impaired glucose tolerance ( J:51826 )

• glucose turnover and glucose infusion rates during hyperglycemic clamp are reduced

decreased glycogen level ( J:51826 )

• net hepatic glycogen synthesis is reduced by about 90% during hyperglycemic clamp studies

insulin resistance ( J:51826 )

• mild insulin resistance

endocrine/exocrine glands

decreased insulin secretion ( J:51826 )

• secrete 70% less insulin in response to glucose stimulus

Mouse Models of Human Disease		DO ID	OMIM ID(s)	Ref(s)
maturity-onset diabetes of the young type 2		DOID:0111100	OMIM:125851	J:51826

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/16/2024 MGI 6.23